Actions

Newsfeed Popular Local Discover Follows Blocks Bookmarks Filters Settings PowerUps Help Updates

stocktitan.net / Share Newsitem

View, share or embed this newsitem using the details below.

Stock Market News Live | StockTitan.net

@stocktitan.net/3 hours3h

IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting

Groundbreaking cancer therapy IMNN-001 shows 35% survival improvement in Phase 2 trials, extending life by 11.1 months. Learn how this DNA-mediated immunotherapy could transform ovarian cancer treatment. FDA meeting scheduled.

https://newsreadery.com/go/1ad64873e3ca3cd0bb02c59e1c04e0cd

Save

Back

Read Full Article